A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects
NCT: NCT04674826 · COMPLETED
Publicidade
ID NCTNCT04674826
EstadoCOMPLETED
Data de início2021-02-08
Conclusão2021-12-29
Resumo breve
The purpose of this trial is to compare the pharmacokinetics (PK), safety, tolerability and immunogenicity of a single dose of 300 mg tralokinumab administered as a 1 × X mL subcutaneous (SC) injection with Device A and 2 × Y mL consecutive SC injections with Device B.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.